CMED Blog | Medical Cannabis Industry Insights

Published: March 24, 2026

Why Medical Cannabis Still Matters:

Key Policy Shifts Across the U.S. in 2026

The medical cannabis landscape is evolving fast, and this past week made one thing clear. Medical programs are not going away. They are expanding, improving, and becoming more patient-focused across the country.

Here are a few of the most important updates from the past week and what they actually mean for patients, providers, and partners like CMED.

Mississippi Expands Patient Access

Mississippi just passed meaningful reforms to its medical cannabis program. Two bills, HB 1152 (the Right to Try Medical Cannabis Act) and HB 895, have cleared both chambers and are headed to the governor’s desk.

These reforms include:

• “Right to Try” provisions for patients with serious, chronic, progressive, or terminal conditions not currently on the state’s qualifying conditions list
• Removal of the 60% THC cap on concentrates, tinctures, oils, and other products
• Extending patient card validity from 12 months to 24 months and eliminating mandatory 6-month follow-up visits

This is a major step toward reducing friction in the patient journey. Longer card durations mean fewer barriers, better retention, and more consistent care. Removing potency caps also gives providers more flexibility to recommend what actually works for the patient, not what fits inside an arbitrary limit.

With nearly 60,000 patients enrolled in Mississippi’s program and 35 counties still lacking a certified practitioner, these reforms are long overdue. Patients who need concentrated products should not be forced to consume more of a lower-potency product just to achieve the same therapeutic relief.

The Right to Try bill passed the House 104–7 and cleared the Senate with strong bipartisan support. According to the Mississippi Free Press, both bills are scheduled to take effect July 1, 2026.

Sources: Mississippi Free Press (March 18, 2026); NORML (March 19, 2026); WLOX (March 23, 2026)

Providers Are Getting Protected in Nebraska

Nebraska is moving forward with legislation that protects medical providers from penalties when recommending cannabis to qualifying patients. The state legislature voted 30–7 to advance Legislative Bill 933, which would protect health care practitioners from criminal, civil, or professional disciplinary penalties solely for recommending medical cannabis or expressing a professional opinion that a patient could benefit from it.

This is a big deal.

One of the biggest constraints in medical programs isn’t patient demand. It’s provider participation. When doctors feel protected, participation increases. When participation increases, access improves. It’s that simple.

Nebraska voters overwhelmingly approved medical cannabis in 2024 with 71% support. Yet nearly two years later, providers have been hesitant to write recommendations due to fear of professional consequences. LB 933 would align Nebraska with 16 of 17 other medical-only states that already offer practitioner protections.

The bill still needs to clear two more rounds of debate and will require 33 votes for final passage, but the momentum is strong. As reported by the Nebraska Examiner, this proposal provides a lower level of protection than any of the 16 other medical-only states that already have such laws.

Sources: Nebraska Examiner (March 20, 2026); Marijuana Moment (March 21, 2026); Unicameral Update (March 20, 2026)

New States Are Getting Closer: Indiana Signals Openness

Indiana continues to signal openness toward legalizing medical cannabis, even as formal legislation stalls in the Republican-controlled statehouse.

Governor Mike Braun stated publicly this past week that with four neighboring states having legalized marijuana in some form, Indiana is “probably going to have to address it.” According to Marijuana Moment, he has previously said he’s “amenable” to the idea of a medical cannabis program.

Even in 2026, there are still states without access. But the tone is shifting. When leadership publicly supports medical use, it’s usually a matter of when, not if. Polling shows 84% of Indiana residents support at least medical cannabis access.

Indiana is one of only 12 states with no effective medical cannabis law, and one of only 19 that still imposes jail time for simple possession. Three of its four neighboring states have legalized adult-use cannabis, and the fourth (Kentucky) has a medical program in progress.

Sources: Marijuana Moment (March 22, 2026); Indiana Capital Chronicle (February 2, 2026)

Insurance Coverage Could Be a Game Changer

New Jersey is considering a proposal that would require workers’ compensation insurance to cover medical cannabis for injured workers.

Senate Bill 3984 and Assembly Bill 1023 were reintroduced in March 2026. The legislation would require workers’ comp, personal injury protection (PIP), and health insurance plans to cover costs associated with medical cannabis for qualifying patients. If insurers cannot pay dispensaries directly, they would be required to reimburse workers for out-of-pocket costs upon proof of payment.

If this moves forward, it changes the entire conversation.

Medical cannabis starts to move from an out-of-pocket wellness decision to a covered treatment option. That’s where real scale and long-term legitimacy come into play. As Ganjapreneur reports, the bill’s sponsors note that medical cannabis could actually lower costs for insurers by offering a more economical alternative to opioids and other high-risk prescriptions.

Currently, only a handful of states require workers’ compensation to cover medical cannabis. New Jersey’s push, combined with recent federal court rulings on the topic, represents a major step toward institutional backing for medical programs. For patients, this means medical cannabis could become as accessible as any other covered treatment.

Sources: Ganjapreneur (March 18, 2026); Business Insurance (March 2026); New Jersey Legislature (A1023/S3984)

Regulation Is Tightening in Some Markets

States like Ohio and Pennsylvania are moving toward stricter THC caps and tighter control over hemp-derived products.

Ohio’s Senate Bill 56 took effect on March 20, 2026, imposing a categorical ban on the sale of intoxicating hemp products outside of licensed dispensaries. The law reduces allowable THC levels in extracts from 90% to 70%, limits flower potency to 35% THC, and requires all THC-infused beverages and edibles to be sold only through state-licensed cannabis retailers.

In Pennsylvania, the Senate Law and Justice Committee voted 10–1 on March 16 to amend SB 49 to align the state’s hemp regulations with the federal government’s forthcoming product ban. The legislation would establish a Cannabis Control Board to consolidate oversight of cannabis and hemp-derived products.

This reinforces something we’ve been saying for a while: medical programs are the most stable and protected channel in the cannabis industry.

When regulations tighten, whether at the state or federal level, medical patients and compliant providers are the ones who benefit from structure, consistency, and long-term viability. The unregulated hemp market is contracting. Licensed, regulated medical programs are not.

Sources: Spectrum News 1 (March 20, 2026); WOSU Public Media (March 19, 2026); Marijuana Moment (March 16, 2026); Cannabis Business Times (March 2026)

The Bigger Picture

Across all of these updates, the trend is clear:

• Medical programs are becoming more patient-friendly
• Providers are being supported, not restricted
• Access is expanding into new states
• Insurance and institutional backing is starting to emerge

This is exactly why medical cannabis continues to matter, even in adult-use markets. It offers:

• Lower cost for patients through tax advantages and potential insurance coverage
• Higher product access and potency options that aren’t available on the recreational side
• Clinical oversight and compliance for patients who need therapeutic guidance
• Long-term program stability that protects both patients and providers

The industry isn’t moving away from medical. It’s refining it. And for patients, providers, and partners, that creates real opportunity.

Ready to Get Your Medical Cannabis Card?

If you’re a patient looking to access the benefits of a medical cannabis program like lower costs, higher potency options, clinical support, and legal protection, CMED can help you get started.

Whether you’re in a state that’s expanding access or you’re navigating a new program, our team is here to simplify the process and connect you with certified providers who understand your needs. Get your medical cannabis card through CMED today.

Visit CMED to learn more about medical cannabis certification, program eligibility, and how to connect with a provider in your state.

Sources

All sources cited in this blog are publicly available news reports and legislative records verified as of March 24, 2026.

1. Mississippi Free Press – “Bills to Remove Medical Cannabis Concentrate Cap, Allow ‘Right-to-Try’ Head to Governor” (March 18, 2026)
2. NORML – “Mississippi Bill Expanding Medical Cannabis Heads to Governor” (March 19, 2026)
3. WLOX – “Mississippi medical cannabis bills head to governor’s desk” (March 23, 2026)
4. The Marijuana Herald – “Mississippi Right to Try Medical Cannabis Act Sent to Governor” (March 17, 2026)
5. Mississippi Legislature – HB 1152 (Right to Try Medical Cannabis Act)
6. Nebraska Examiner – “Bill advances to protect Nebraska health care providers” (March 20, 2026)
7. Marijuana Moment – “Nebraska Legislature Approves Bill To Protect Doctors” (March 21, 2026)
8. Unicameral Update – “Legal protections advanced for medical cannabis recommendations” (March 20, 2026)
9. Marijuana Moment – “Indiana Will ‘Have To Address’ Marijuana Legalization” (March 22, 2026)
10. Indiana Capital Chronicle – “Indiana keeps bucking marijuana legalization” (February 2, 2026)
11. Ganjapreneur – “New Jersey Bill Would Require Workers’ Comp Insurers to Cover Medical Cannabis” (March 18, 2026)
12. Business Insurance – “N.J. bill mandating comp coverage for medical cannabis reintroduced” (March 2026)
13. New Jersey Legislature – Assembly Bill 1023
14. NORML – “Federal Appeals Court: Workers’ Comp Can’t Reimburse for Medical Cannabis” (March 12, 2026)
15. Spectrum News 1 – “Ohio’s marijuana and hemp rules take effect” (March 20, 2026)
16. WOSU Public Media – “Effort to repeal ban on hemp, THC drinks, fails” (March 19, 2026)
17. Marijuana Moment – “Pennsylvania Senators Amend Cannabis Regulation Bill” (March 16, 2026)

18. Cannabis Business Times – “Pennsylvania Moves to Align Hemp Product Regulations With Federal Ban” (March 2026)